{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:56:00Z","timestamp":1781643360286,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study aimed to evaluate the knowledge, attitudes, and practices (KAP) regarding long-acting antiretroviral therapy (LA-ART) among HIV\/AIDS patients. A cross-sectional study was conducted at the Infection Center of Beijing Youan Hospital between December 2024 and May 2025. Data were collected using a structured questionnaire comprising demographic variables and KAP-related items. A total of 919 questionnaires were collected; after excluding 93 responses (declined consent, abnormal height\/weight entries, failed logic-check questions, and uniform responses), 826 valid questionnaires were included in the final analysis, yielding a valid response rate of 89.88%. Most participants resided in urban areas (62.0%) and were currently employed (72.0%), with over half (52.9%) holding an associate or bachelor\u2019s degree. Their knowledge, attitude, and practice scores were 14.38\u2009\u00b1\u20095.52 (possible range: 0\u201336), 39.71\u2009\u00b1\u20094.36 (possible range: 12\u201360), and 22.29\u2009\u00b1\u20092.99 (possible range: 9\u201327), respectively. The structural equation modeling results showed that knowledge had direct effects on attitude (\u03b2\u2009=\u20090.427,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.016) and practice (\u03b2\u2009=\u20090.132,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.003). Meanwhile, attitude had a direct impact on practice (\u03b2\u2009=\u20090.460,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.034). Furthermore, knowledge indirectly affected practice through attitude (\u03b2\u2009=\u20090.197,\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.014). HIV\/AIDS patients demonstrated insufficient knowledge, a generally neutral attitude, yet reported positive practices regarding LA-ART. Future clinical interventions should prioritize structured, evidence-based educational programs to enhance patient understanding and shift attitudes.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-44035-0","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T22:55:04Z","timestamp":1773788104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knowledge attitudes and practices towards long-acting antiretroviral therapy in HIV\/AIDS patients"],"prefix":"10.1038","volume":"16","author":[{"given":"Meixin","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luyao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiyi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"44035_CR1","unstructured":"UNAIDS & Global HIV & AIDS statistics \u2014 Fact sheet [Available from: www.unaids.org\/en\/resources\/fact-sheet"},{"key":"44035_CR2","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11904-019-00478-x","volume":"17","author":"W Cao","year":"2020","unstructured":"Cao, W., Hsieh, E. & Li, T. Optimizing treatment for adults with HIV\/AIDS in China: successes over two decades and remaining challenges. Curr. HIV\/AIDS Rep. 17, 26\u201334 (2020).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"44035_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/cells13010064","volume":"13","author":"Y Matsui","year":"2023","unstructured":"Matsui, Y. & Miura, Y. Advancements in Cell-Based Therapies for HIV Cure. Cells 13, 64 (2023).","journal-title":"Cells"},{"key":"44035_CR4","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1097\/CM9.0000000000001842","volume":"134","author":"JJ Xu","year":"2021","unstructured":"Xu, J. J. et al. Prevention and control of HIV\/AIDS in China: lessons from the past three decades. Chin. Med. J. (Engl). 134, 2799\u20132809 (2021).","journal-title":"Chin. Med. J. (Engl)"},{"key":"44035_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-6405-11-19","volume":"11","author":"Y Shen","year":"2014","unstructured":"Shen, Y. et al. The prevalence of transmitted HIV drug resistance among MSM in Anhui province, China. AIDS Res. Ther. 11, 19 (2014).","journal-title":"AIDS Res. Ther."},{"key":"44035_CR6","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1186\/s12889-025-23121-4","volume":"25","author":"Y Lu","year":"2025","unstructured":"Lu, Y. et al. Global and regional disease burden of HIV\/AIDS from 1990 to 2021 and projections to 2030. BMC Public. Health. 25, 1928 (2025).","journal-title":"BMC Public. Health"},{"key":"44035_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1097\/COH.0000000000000588","volume":"15","author":"N Phanuphak","year":"2020","unstructured":"Phanuphak, N. & Gulick, R. M. HIV treatment and prevention 2019: current standards of care. Curr. Opin. HIV AIDS. 15, 4\u201312 (2020).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"44035_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1097\/QAI.0000000000003500","volume":"97","author":"CM Luc","year":"2024","unstructured":"Luc, C. M. et al. Acceptability of long-acting Cabotegravir\u2009+\u2009Rilpivirine in a Large, Urban, ambulatory HIV clinic. J. Acquir. Immune Defic. Syndr. 97, 409\u2013415 (2024).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"44035_CR9","doi-asserted-by":"publisher","first-page":"e3361","DOI":"10.1097\/MD.0000000000003361","volume":"95","author":"WM Bezabhe","year":"2016","unstructured":"Bezabhe, W. M., Chalmers, L., Bereznicki, L. R. & Peterson, G. M. Adherence to antiretroviral therapy and virologic failure: a meta-analysis. Med. (Baltim). 95, e3361 (2016).","journal-title":"Med. (Baltim)."},{"key":"44035_CR10","doi-asserted-by":"publisher","first-page":"5221","DOI":"10.1038\/s41598-024-54609-5","volume":"14","author":"OS Muhammed","year":"2024","unstructured":"Muhammed, O. S. et al. Treatment burden and regimen fatigue among patients with HIV and diabetes attending clinics of Tikur Anbessa specialized hospital. Sci. Rep. 14, 5221 (2024).","journal-title":"Sci. Rep."},{"key":"44035_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12981-020-00283-2","volume":"17","author":"J Mayo-Wilson","year":"2020","unstructured":"Mayo-Wilson, J. Habit formation in support of antiretroviral medication adherence in clinic-enrolled HIV-infected adults: a qualitative assessment using free-listing and unstructured interviewing in Kampala, Uganda. AIDS Res. Ther. 17, 30 (2020).","journal-title":"AIDS Res. Ther."},{"key":"44035_CR12","doi-asserted-by":"crossref","unstructured":"Buz\u00f3n-Mart\u00edn, L. et al., Long-acting cabotegravir and rilpivirine for the treatment of people with HIV: current landscape and challenges ahead. J Antimicrob. Chemother (2025).","DOI":"10.1093\/jac\/dkaf246"},{"key":"44035_CR13","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jama.2022.22246","volume":"329","author":"RT Gandhi","year":"2023","unstructured":"Gandhi, R. T. et al. Antiretroviral drugs for treatment and prevention of hiv infection in adults: 2022 recommendations of the international antiviral society-USA panel. Jama 329, 63\u201384 (2023).","journal-title":"Jama"},{"key":"44035_CR14","doi-asserted-by":"publisher","first-page":"e26006","DOI":"10.1002\/jia2.26006","volume":"25","author":"CP Garris","year":"2022","unstructured":"Garris, C. P. et al. Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings: results from the CUSTOMIZE hybrid III implementation-effectiveness study. J. Int. AIDS Soc. 25, e26006 (2022).","journal-title":"J. Int. AIDS Soc."},{"key":"44035_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1097\/QAI.0000000000002466","volume":"85","author":"G Rizzardini","year":"2020","unstructured":"Rizzardini, G. et al. Long-acting injectable cabotegravir\u2009+\u2009rilpivirine for HIV maintenance therapy: week 48 pooled analysis of phase 3 ATLAS and FLAIR trials. J. Acquir. Immune Defic. Syndr. 85, 498\u2013506 (2020).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"44035_CR16","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s40121-023-00840-y","volume":"12","author":"S Moreno","year":"2023","unstructured":"Moreno, S. et al. Cabotegravir and rilpivirine long-acting antiretroviral therapy administered every 2 months is cost-effective for the treatment of HIV-1 in Spain. Infect. Dis. Ther. 12, 2039\u20132055 (2023).","journal-title":"Infect. Dis. Ther."},{"key":"44035_CR17","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1002\/nop2.1384","volume":"10","author":"A Huang","year":"2023","unstructured":"Huang, A. et al. Knowledge, attitudes and practices concerning catheter-associated urinary tract infection amongst healthcare workers: a mixed methods systematic review. Nurs. Open. 10, 1281\u20131304 (2023).","journal-title":"Nurs. Open."},{"key":"44035_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/RMHP.S287379","volume":"14","author":"N Twinamasiko","year":"2021","unstructured":"Twinamasiko, N. et al. Assessing knowledge, attitudes and practices towards COVID-19 public health preventive measures among patients at Mulago national referral hospital. Risk Manag Healthc. Policy. 14, 221\u2013230 (2021).","journal-title":"Risk Manag Healthc. Policy"},{"key":"44035_CR19","doi-asserted-by":"crossref","unstructured":"Rathomi, H. S., Dale, T., Mavaddat, N. & Thompson, S. C. General practitioners\u2019 knowledge, attitudes, and practices of dietary advice for weight control in their overweight patients: a scoping review. Nutrients. 15, (2023).","DOI":"10.3390\/nu15132920"},{"key":"44035_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2991\/jegh.k.201101.001","volume":"11","author":"A AlJohani","year":"2021","unstructured":"AlJohani, A., Karuppiah, K. & Al Mutairi, A. Al Mutair, A. Narrative review of infection control knowledge and attitude among healthcare workers. J. Epidemiol. Glob Health. 11, 20\u201325 (2021).","journal-title":"J. Epidemiol. Glob Health"},{"key":"44035_CR21","doi-asserted-by":"publisher","first-page":"e0249025","DOI":"10.1371\/journal.pone.0249025","volume":"16","author":"L Youssef","year":"2021","unstructured":"Youssef, L. et al. Knowledge, attitudes and practices towards people living with HIV\/AIDS in Lebanon. PLoS One. 16, e0249025 (2021).","journal-title":"PLoS One"},{"key":"44035_CR22","doi-asserted-by":"publisher","first-page":"804626","DOI":"10.3389\/fpubh.2021.804626","volume":"9","author":"L Zhang","year":"2021","unstructured":"Zhang, L. et al. HIV\/AIDS-related knowledge and attitudes among chinese college students and associated factors: a cross-sectional study. Front. Public. Health. 9, 804626 (2021).","journal-title":"Front. Public. Health"},{"key":"44035_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1089\/aid.2023.0150","volume":"41","author":"M Li","year":"2025","unstructured":"Li, M. et al. Willingness to switch to long-acting injectable cabotegravir and rilpivirine every 2 months for people living with HIV in Nanjing, China. AIDS Res. Hum. Retroviruses. 41, 107\u2013112 (2025).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"44035_CR24","doi-asserted-by":"publisher","first-page":"e0190487","DOI":"10.1371\/journal.pone.0190487","volume":"13","author":"D Kerrigan","year":"2018","unstructured":"Kerrigan, D. et al. Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir\u2009+\u2009rilpivirine (LATTE-2) in the United States and Spain. PLoS One. 13, e0190487 (2018).","journal-title":"PLoS One"},{"key":"44035_CR25","doi-asserted-by":"publisher","first-page":"232595822110005","DOI":"10.1177\/23259582211000517","volume":"20","author":"JM Simoni","year":"2021","unstructured":"Simoni, J. M. et al. Lighten this burden of ours: acceptability and preferences regarding injectable antiretroviral treatment among adults and youth living with HIV in Coastal Kenya. J. Int. Assoc. Provid AIDS Care. 20, 23259582211000517 (2021).","journal-title":"J. Int. Assoc. Provid AIDS Care"},{"key":"44035_CR26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/ID9.0000000000000044","volume":"2","author":"AIDS, Hepatitis C Professional Grou","year":"2022","unstructured":"AIDS, Hepatitis C Professional Group, S. o. I. D., Chinese medical association, control, C. C. f. D.& prevention. Chinese guidelines for the diagnosis and treatment of HIV\/AIDS (2021 edition). Infect. Dis. Immun. 2, 145\u2013167 (2022).","journal-title":"Infect. Dis. Immun."},{"key":"44035_CR27","doi-asserted-by":"publisher","first-page":"957630","DOI":"10.3389\/fpubh.2022.957630","volume":"10","author":"F Lee","year":"2022","unstructured":"Lee, F. & Suryohusodo, A. A. Knowledge, attitude, and practice assessment toward COVID-19 among communities in East Nusa Tenggara, Indonesia: A cross-sectional study. Front. Public. Health. 10, 957630 (2022).","journal-title":"Front. Public. Health"},{"key":"44035_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12913-019-4173-3","volume":"19","author":"M Raberahona","year":"2019","unstructured":"Raberahona, M. et al. Knowledge, attitudes, perception and practices regarding antiretroviral therapy among HIV-infected adults in Antananarivo, Madagascar: a cross-sectional survey. BMC Health Serv. Res. 19, 341 (2019).","journal-title":"BMC Health Serv. Res."},{"key":"44035_CR29","doi-asserted-by":"publisher","first-page":"e46767","DOI":"10.2196\/46767","volume":"9","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Safety and Efficacy of Long-Acting Injectable Agents for HIV-1: Systematic Review and Meta-Analysis. JMIR Public. Health Surveill. 9, e46767 (2023).","journal-title":"JMIR Public. Health Surveill"},{"key":"44035_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/17441692.2020.1858137","volume":"17","author":"JL Glick","year":"2022","unstructured":"Glick, J. L. et al. ART uptake and adherence among female sex workers (FSW) globally: A scoping review. Glob. Public Health. 17, 254\u2013284 (2022).","journal-title":"Glob. Public Health"},{"key":"44035_CR31","doi-asserted-by":"crossref","unstructured":"Majeed, F. et al. Modelling Predictive Factors of Knowledge, Attitudes and Practices towards HIV\/AIDS Transmission and Their Interlinked Role: A Facility-Based Cross-Sectional Study Among HIV\/AIDS Patients in Lahore, Pakistan: Knowledge, Attitudes, and Practices on HIV\/AIDS Transmission. Pakistan J. Health Sciences 218\u2013224 (2024).","DOI":"10.54393\/pjhs.v5i10.2395"},{"key":"44035_CR32","doi-asserted-by":"publisher","first-page":"e20210307","DOI":"10.1590\/0034-7167-2021-0307","volume":"75","author":"MAC Lima","year":"2022","unstructured":"Lima, M. A. C. et al. Knowledge, attitude and practice of people with HIV regarding a healthy lifestyle: clinical trial. Revista Brasileira de Enfermagem. 75, e20210307 (2022).","journal-title":"Revista Brasileira de Enfermagem"},{"key":"44035_CR33","doi-asserted-by":"crossref","unstructured":"Shrestha, S. et al. Knowledge, attitude, practice, and adherence to antiretroviral therapy among people living with HIV in Nepal. AIDS research and treatment. 7292115 (2023). (2023).","DOI":"10.1155\/2023\/7292115"},{"key":"44035_CR34","doi-asserted-by":"publisher","first-page":"e0239513","DOI":"10.1371\/journal.pone.0239513","volume":"15","author":"C Iwuji","year":"2020","unstructured":"Iwuji, C. et al. Test but not treat: Community members\u2019 experiences with barriers and facilitators to universal antiretroviral therapy uptake in rural KwaZulu-Natal, South Africa. PloS one. 15, e0239513 (2020).","journal-title":"PloS one"},{"key":"44035_CR35","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1007\/s11524-023-00755-6","volume":"100","author":"AB Collins","year":"2023","unstructured":"Collins, A. B. et al. Perceptions of long-acting injectable antiretroviral therapy among people living with HIV who use drugs and service providers: a qualitative analysis in Rhode Island. J. Urban Health. 100, 1062\u20131073 (2023).","journal-title":"J. Urban Health"},{"key":"44035_CR36","first-page":"179","volume":"11","author":"C Fernandez","year":"2019","unstructured":"Fernandez, C. & van Halsema, C. L. Evaluating cabotegravir\/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential. HIV AIDS (Auckl). 11, 179\u2013192 (2019).","journal-title":"HIV AIDS (Auckl)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44035-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44035-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44035-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:21:34Z","timestamp":1781641294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44035-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44035"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44035-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board of Beijing Youan Hospital (LL-2024-150-K). All participants were informed about the study protocol and provided written informed consent to participate in the study. I confirm that all methods were performed in accordance with the relevant guidelines. All procedures were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"15840"}}